Propath has partnered with Revolune as its first service provider, delivering a complete sample‑to‑data solution for multiplex immunofluorescence workflows. This collaboration expands access to Revolune’s flexible staining technology through a fully managed service model, enabling customers to adopt advanced multiplex approaches without the need to establish new workflows internally.
The partnership is designed to support a wide range of users, from teams transitioning from legacy multiplex platforms to those seeking a more adaptable approach to panel design and execution. By combining Revolune’s direct‑labelling chemistry with Propath’s expertise in assay development, tissue processing, imaging, and spatial analysis, the collaboration provides a practical route from panel concept through to high‑quality, interpretable data.
Through this integrated service, Propath can support key stages of workflow implementation, including panel feasibility assessment, assay transfer from existing IHC or multiplex methods, staining and imaging, downstream data analysis and complimentary services such as histology, IHC and spatial transcriptomics. This ensures that customers can evaluate and deploy new multiplex strategies with confidence, supported by an experienced scientific partner.
Importantly, the partnership enables both flexibility and scalability. Customers can explore customised panel design tailored to their specific biological questions, while maintaining the option to transition workflows in-house if desired. Alternatively, projects can be delivered entirely through Propath as a managed service, providing a streamlined and efficient path to data generation.
This collaboration reflects Propath’s ongoing commitment to enabling access to emerging spatial biology technologies and supporting biopharma partners across the full spectrum of research and development. By integrating innovative platforms with robust, end‑to‑end service delivery, Propath continues to provide practical solutions that accelerate tissue‑based biomarker studies and translational research.
